Global Handheld Ultrasound Device System market size is valued at USD 2.8 billion in 2025 and is projected to expand at a 10.4% CAGR through 2033, propelled by emergency medicine adoption, AI-enabled workflow, and value-based purchasing. Regulatory tailwinds—notably the FDA’s 510(k) fast-track for AI-enhanced probes—are accelerating market forecast visibility, while supply-chain resilience (semiconductor on-shoring) stabilizes unit economics. North America commands 38% share, but Asia-Pacific will outpace all regions with a 13% CAGR, fueled by rural telehealth subsidies in China and India. Competitive intensity is rising as Butterfly, Philips, and GE Healthcare launch subscription pricing, compressing ASPs yet expanding industry expansion into outpatient and home-care segments.